Together, beyond animal health
COMPOSITION
MAXIMUNE® 8 is an inactivated oil emulsion vaccine containing three Infectious Bursal Disease viruses (standard, variant A and E strains), and three reoviruses including strain S1133 (Tenosynovitis pathotype), strain 2408 (Malabsorption pathotype) and strain SS412 (Distinct serotype from the S1133 type reovirus and a causative agent of proventriculitis and malabsorption in broilers). MAXIMUNE® 8 also contains Newcastle Disease virus and Infectious Bronchitis viruses (Mass 41 and Mass Holland strains). All viruses in MAXIMUNE® 8 are non-cloned isolates produced in SPF chicken egg substrates or in bursal of SPF chickens.
INDICATIONS
The vaccine is recommended for the vaccination of healthy chickens at least 18 weeks of age as an aid in the prevention of Newcastle Disease and Infectious Bronchitis virus (Mass type). Breeder vaccination also provides maternal antibodies to progeny of breeder hens for the prevention of Bursal Disease caused by standard and variant strains and Tenosynovitis and Malabsorption caused by reoviruses of the standard and SS412 types. Optimum results with MAXIMUNE® 8 require that chickens are properly primed with live Infectious Bursal Disease vaccine, Tenosynovitis vaccine and bronchitis vaccine of the Mass type at least four weeks in advance of administration of the inactivated vaccine.
ADMINISTRATION AND DOSAGE
Vaccinate chickens with 0.5 ml (1/2 cc) per bird. The vaccine should be administered by the subcutaneous route in the back of the neck. Refer to the product label for specific use directions and precautions.
STORAGE
- Store vaccine between
+2°C and +8°C or 35°F and 45°F
- Protect from light
- Do not freeze
PACKAGED
1,000 doses in each 500 ml bottle
10 X 1,000 dose bottles/box
20 X 1,000 dose bottles/box
WARNING
This product contains oil based adjuvant; accidental injection into a human may cause a serious localized reaction. Seek expert medical attention immediately.